003000 — Bukwang Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Market Cap
KR₩357bn
Enterprise Value
KR₩298bn
Revenue
KR₩160bn

Annual balance sheet for Bukwang Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	89,591	84,277	85,517	151,227	130,086
Net Total Accounts Receivable
Net Total Receivables	106,348	95,550	93,045	45,041	31,251
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	248,209	220,095	218,741	254,179	203,739
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	106,298	124,531	123,960	122,789	141,481
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	400,969	397,417	400,929	429,017	373,180
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	61,204	36,995	44,603	97,544	35,398
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	142,470	127,809	137,712	202,706	129,505
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	258,499	269,608	263,217	226,311	243,676
Total Liabilities & Shareholders' Equity	400,969	397,417	400,929	429,017	373,180
Total Common Shares Outstanding